Physician

Stacey Allen Finley Hudson, MD

According to 2025 Medicare claims, Stacey Hudson, MD (NPI: 1386615672) practices otolaryngology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. Hudson uses personal NPI as billing NPI and primary practice location at 89521-8977.

Hudson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 665 traditional Medicare patients, billed 2,676 HCPCS/CPT codes, and received $929,699 in Medicare payments. The top billing code was 31295 (Dilation of nasal sinus using an endoscope). Part D data shows 3,205 prescription claims across 804 beneficiaries totaling $114,981 in drug costs, led by Azelastine Hcl (Azelastine Hcl). DME data shows 12 claims. Open Payments data shows 3 records totaling $86. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $54,281 to $114,981. In contrast, DME billing represents a smaller volume and moved from a higher plateau to a lower plateau, from $1,670 to $383.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	514	1,537	$651,600
2016	533	1,724	$794,780
2017	554	1,991	$786,651
2018	598	2,177	$1,065,055
2019	665	2,305	$1,110,556
2020	555	1,923	$1,025,910
2021	551	1,861	$1,017,140
2022	588	2,017	$1,070,603
2023	621	2,348	$971,754
2024	665	2,676	$929,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	365	1,304	$54,281
2016	402	1,410	$47,430
2017	449	1,722	$48,562
2018	486	1,945	$51,181
2019	542	2,195	$51,149
2020	606	2,741	$70,559
2021	652	2,809	$83,883
2022	705	2,910	$102,223
2023	743	2,897	$121,028
2024	804	3,205	$114,981

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$770
2016	N/R	N/R	N/R
2017	N/R	12	$574
2018	N/R	74	$5,925
2019	N/R	53	$3,381
2020	N/R	85	$4,637
2021	N/R	59	$2,777
2022	12	60	$2,815
2023	N/R	55	$1,376
2024	N/R	12	$957

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31295	Dilation of nasal sinus using an endoscope	141	143	$1,749
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	227	227	$113
70486	Ct scan of face without contrast	296	384	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	376	572	$91
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	311	404	$66

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Azelastine Hcl	Azelastine Hcl	489	30,027	$19,501
Fluticasone Propionate	Fluticasone Propionate	430	28,233	$6,326
Cefdinir	Cefdinir	247	3,416	$5,845
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	42	432	$5,272
Ipratropium Bromide	Ipratropium Bromide	166	6,341	$5,185

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	12	$957

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$86	Stryker Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stacey Allen Finley Hudson, MD?

Tedicare shows public-source Medicare data for Stacey Allen Finley Hudson, MD (NPI 1386615672), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stacey Allen Finley Hudson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stacey Allen Finley Hudson, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Stacey Allen Finley Hudson, MD have Open Payments data?

Stacey Allen Finley Hudson, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.